Shares of major Indian hospital operators fell sharply on September 30, 2026, as investors reacted to the Supreme Court of India's renewed scrutiny of medicine mark-ups at private hospitals. Apollo…
Sun Pharma is reportedly planning a ₹100 billion (about $1.04 billion) rupee bond sale to partly refinance the near-$12 billion bridge loan tied to its pending Organon acquisition, according to Reuters.
PharmFormulator LLC has launched PharmFormulator.com, a subscription-based research platform aimed at giving pharmaceutical researchers and healthcare professionals greater access to formulation information for ophthalmic drug products. The database brings together…
Lords Mark Industries Limited is moving its AI-powered breast cancer screening technology into the final phase of clinical trials, bringing the company closer to its planned commercial launch in international…
The Estée Lauder Companies is committing $15 million over five years to establish a new international research initiative focused on breast cancer among younger women. Created in partnership with the…
HKSH Medical Group and United Imaging Healthcare have brought Hong Kong's first long-axial PET/CT system to HKSH Cancer Centre, adding a new imaging platform for cancer diagnosis, treatment planning and…
Novo Nordisk is setting its sights on more than DKK 150 billion, equivalent to roughly $23 billion, in annual risk-adjusted sales from pipeline medicines by 2035 as the pharmaceutical company…
Glenmark Pharmaceuticals has introduced GLIPIQ, a semaglutide-based treatment for Type 2 Diabetes Mellitus, in India, adding a new locally available option to the country's growing market for GLP-1 therapies. The…